Co Gmbh Bioventures Mpm III Rigel Pharmaceuticals Inc

As of September 15, 2004


Co Gmbh Bioventures Mpm III Net Worth

  • Net worth is estimated to be at least $96.24M
  • Owns at least 1,687,072 units of Rigel Pharmaceuticals Inc stock
  • Sold an estimated value of $22.19M in the last 7 months at Rigel Pharmaceuticals Inc

Co Gmbh Bioventures Mpm III Trading

  • Largest sale of shares was 316,302 units , worth over $6.3M on April 13, 2004
  • In total has made about 17 transactions over 7 months
  • Usually trades in June, with the busiest year in 2004

MPM BIOVENTURES III QP LP, MPM BIOVENTURES III LP, CO GMBH BIOVENTURES MPM III, FUND PARALLEL BIOVENTURES MPM III, MPM ASSET MANAGEMENT INVESTORS BVIII LLC, MPM BIOVENTURES III GP LP, MPM BIOVENTURES III LLC, NICHOLAS GALAKATOS, MICHAEL STEINMETZ, KURT WHEELER

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Co Gmbh Bioventures Mpm III Mailing Address

  • Mailing address is The John Hancock Tower 200 Clarendon Street, 54th Floor Boston MA 02116 MA

Rigel Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 0 unit bought on November 20, 2019 by Esteban Masuda worth over $0
  • In the last 15 years, insiders at Rigel Pharmaceuticals Inc sold an estimated value of $206.52M and bought an estimated value of $21.15M
  • The most active traders are Dolly Vance, EVP Corp. Affairs,  Jean Deleage, Director,  and Raul Rodriguez, CEO
  • Insider trading is most common in May, with the busiest year in 2004

RIGEL PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1